Epstein-barr virus infection and sporadic breast cancer risk: A meta-analysis

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Huo, Qiang ^a   Zhang, Ning ^a   Yang, Qifeng ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ASIA; BREAST CANCER; CANCER RISK; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DNA DETERMINATION; EPSTEIN BARR VIRUS INFECTION; HUMAN; KAPPA STATISTICS; LOGISTIC REGRESSION ANALYSIS; POLYMERASE CHAIN REACTION; PREVALENCE; REVIEW; STATISTICAL ANALYSIS; STATISTICAL MODEL; TREND STUDY; UNITED STATES; VIRUS DETECTION; ARTICLE; BREAST TUMOR; CLASSIFICATION; EPSTEIN BARR VIRUS; FEMALE; GENETICS; META ANALYSIS; PHYSIOLOGY; PUBLISHING; RISK; RISK FACTOR; VIROLOGY;

BREAST NEOPLASMS; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; LINEAR MODELS; ODDS RATIO; POLYMERASE CHAIN REACTION; PREVALENCE; PUBLICATION BIAS; RISK FACTORS;

EID: 84857394727     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031656     Document Type: Review

References (47)

1. Serraino D, Piselli P, Scognamiglio P, (2001) Viral infections and cancer: epidemiological aspects. J Biol Regul Homeost Agents 15: 224-228.
2. Labrecque LG, Barnes DM, Fentiman IS, Griffin BE, (1995) Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res 55: 39-45.
3. Fawzy S, Sallam M, Awad NM, (2008) Detection of Epstein-Barr virus in breast carcinoma in Egyptian women. Clin Biochem 41: 486-492.
4. Tsai J-H, Tsai C-H, Cheng M-H, Lin S-J, Xu F-L, et al. (2005) Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. J Med Virol 75: 276-281.
5. Preciado MV, Chabay PA, De Matteo EN, Gonzalez P, Grinstein S, et al. (2005) Epstein-Barr virus in breast carcinoma in Argentina. Arch Pathol Lab Med 129: 377-381.
6. Kalkan A, Ozdarendeli A, Bulut Y, Yekeler H, Cobanoglu B, et al. (2005) Investigation of Epstein-Barr virus DNA in formalin-fixed and paraffin- embedded breast cancer tissues. Medical principles and practice: international journal of the Kuwait University, Health Science Centre 14: 268-271.
7. Perrigoue JG, den Boon JA, Friedl A, Newton MA, Ahlquist P, et al. (2005) Lack of association between EBV and breast carcinoma. Cancer Epidemiol Biomarkers Prev 14: 809-814.
8. Preciado MV, (2003) Lack of evidence for an association of Epstein-Barr virus infection with breast carcinoma-another point of view. Breast Cancer Res 5: E6; author reply E7.
9. Grinstein S, Preciado MV, Gattuso P, Chabay PA, Warren WH, et al. (2002) Demonstration of Epstein-Barr virus in carcinomas of various sites. Cancer Res 62: 4876-4878.
10. Fina F, Romain S, Ouafik L, Palmari J, Ben Ayed F, et al. (2001) Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas. Br J Cancer 84: 783-790.
11. Bonnet M, Guinebretiere JM, Kremmer E, Grunewald V, Benhamou E, et al. (1999) Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 91: 1376-1381.
12. Subramanian C, Robertson ES, (2002) The metastatic suppressor Nm23-H1 interacts with EBNA3C at sequences located between the glutamine- and proline-rich domains and can cooperate in activation of transcription. J Virol 76: 8702-8709.
13. Subramanian C, Knight JS, Robertson ES, (2002) The Epstein Barr nuclear antigen EBNA3C regulates transcription, cell transformation and cell migration. Front Biosci 7: d704-716.
14. Kraus RJ, Mirocha SJ, Stephany HM, Puchalski JR, Mertz JE, (2001) Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus. J Virol 75: 867-877.
15. Fan H, Gulley ML, (2001) Epstein-Barr viral load measurement as a marker of EBV-related disease. Mol Diagn 6: 279-289.
16. Yasui Y, Potter JD, Stanford JL, Rossing MA, Winget MD, et al. (2001) Breast cancer risk and "delayed" primary Epstein-Barr virus infection. Cancer Epidemiol Biomarkers Prev 10: 9-16.
17. Trabelsi A, Rammeh S, Stita W, Mokni M, Mourou A, et al. (2008) Detection of Epstein-Barr virus in breast cancers with lymphoid stroma. Ann Biol Clin 66: 59-62.
18. Hsu JL, Glaser SL, (2000) Epstein-barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit Rev Oncol Hematol 34: 27-53.
19. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
20. DerSimonian R, Kacker R, (2007) Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 28: 105-114.
21. Harbord RM, Egger M, Sterne JA, (2006) A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 25: 3443-3457.
22. Kulka J, Kovalszky I, Svastics E, Berta M, Fule T, (2008) Lymphoepithelioma-like carcinoma of the breast: not Epstein-Barr virus-, but human papilloma virus-positive. Hum Pathol 39: 298-301.
23. Perkins RS, Sahm K, Marando C, Dickson-Witmer D, Pahnke GR, et al. (2006) Analysis of Epstein-Barr virus reservoirs in paired blood and breast cancer primary biopsy specimens by real time PCR. Breast Cancer Res 8: R70.
24. Arbach H, Viglasky V, Lefeu F, Guinebretiere J-M, Ramirez V, et al. (2006) Epstein-Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol). J Virol 80: 845-853.
25. Thorne LB, Ryan JL, Elmore SH, Glaser SL, Gulley ML, (2005) Real-time PCR measures Epstein-Barr Virus DNA in archival breast adenocarcinomas. Diagn Mol Pathol 14: 29-33.
26. Xue SA, Lampert IA, Haldane JS, Bridger JE, Griffin BE, (2003) Epstein-Barr virus gene expression in human breast cancer: protagonist or passenger? Br J Cancer 89: 113-119.
27. Murray PG, Lissauer D, Junying J, Davies G, Moore S, et al. (2003) Reactivity with A monoclonal antibody to Epstein-Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of the EBV genome. Cancer Res 63: 2338-2343.
28. Herrmann K, Niedobitek G, (2003) Lack of evidence for an association of Epstein-Barr virus infection with breast carcinoma. Breast Cancer Res 5: R13-17.
29. Chu PG, Chang KL, Chen YY, Chen WG, Weiss LM, (2001) No significant association of Epstein-Barr virus infection with invasive breast carcinoma. Am J Pathol 159: 571-578.
30. Cristina S, Boldorini R, Brustia F, Monga G, (2000) Lymphoepithelioma-like carcinoma of the breast. An unusual pattern of infiltrating lobular carcinoma. Virchows Arch 437: 198-202.
31. Brink AA, van Den Brule AJ, van Diest P, Meijer CJ, (2000) Re: detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 92: 655-656; author reply 656.
32. Luqmani YA, Shousha S, (1995) Presence of Epstein-Barr virus in breast carcinoma. Int J Oncol 6: 899-903.
33. Lespagnard L, Cochaux P, Larsimont D, Degeyter M, Velu T, et al. (1995) Absence of Epstein-Barr virus in medullary carcinoma of the breast as demonstrated by immunophenotyping, in situ hybridization and polymerase chain reaction. Am J Clin Pathol 103: 449-452.
34. Horiuchi K, Mishima K, Ohsawa M, Aozasa K, (1994) Carcinoma of stomach and breast with lymphoid stroma: localisation of Epstein-Barr virus. J Clin Pathol 47: 538-540.
35. Gaffey MJ, Frierson HF, Mills SE, Boyd JC, Zarbo RJ, et al. (1993) Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significance. Mod Pathol 6: 721-728.
36. Murray PG, Young LS, (2002) The Role of the Epstein-Barr virus in human disease. Front Biosci 7: d519-540.
37. McCall SA, Lichy JH, Bijwaard KE, Aguilera NS, Chu WS, et al. (2001) Epstein-Barr virus detection in ductal carcinoma of the breast. J Natl Cancer Inst 93: 148-150.
38. Sugawara Y, Mizugaki Y, Uchida T, Torii T, Imai S, et al. (1999) Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression. Virology 256: 196-202.
39. Crawford DH, (2001) Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 356: 461-473.
40. Glaser SL, Hsu JL, Gulley ML, (2004) Epstein-Barr virus and breast cancer: state of the evidence for viral carcinogenesis. Cancer Epidemiol Biomarkers Prev 13: 688-697.
41. Khanna R, Tellam J, Duraiswamy J, Cooper L, (2001) Immunotherapeutic strategies for EBV-associated malignancies. Trends Mol Med 7: 270-276.
42. Cox B, Richardson A, Graham P, Gislefoss RE, Jellum E, et al. (2010) Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study. Br J Cancer 102: 1665-1669.
43. Deshpande CG, Badve S, Kidwai N, Longnecker R, (2002) Lack of expression of the Epstein-Barr Virus (EBV) gene products, EBERs, EBNA1, LMP1, and LMP2A, in breast cancer cells. Lab Invest 82: 1193-1199.
44. Dadmanesh F, Peterse JL, Sapino A, Fonelli A, Eusebi V, (2001) Lymphoepithelioma-like carcinoma of the breast: lack of evidence of Epstein-Barr virus infection. Histopathology 38: 54-61.
45. Glaser SL, Ambinder RF, DiGiuseppe JA, Horn-Ross PL, Hsu JL, (1998) Absence of Epstein-Barr virus EBER-1 transcripts in an epidemiologically diverse group of breast cancers. Int J Cancer 75: 555-558.
46. Chu JS, Chen CC, Chang KJ, (1998) In situ detection of Epstein-Barr virus in breast cancer. Cancer Lett 124: 53-57.
47. Mazouni C, Fina F, Romain S, Ouafik L, Bonnier P, et al. (2011) Epstein-Barr virus as a marker of biological aggressiveness in breast cancer. Br J Cancer 104: 332-337.